The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: The modified dermal backflow stage and concept of subclinical lymphedema

Plastic and Reconstructive Surgery

Volumn 128, Issue 4, 2011, Pages

  Yamamoto, Takumi ^a   Matsuda, Nana ^a   Doi, Kentaro ^a   Oshima, Azusa ^a   Yoshimatsu, Hidehiko ^a   Todokoro, Takeshi ^a   Ogata, Fusa ^a   Mihara, Makoto ^a   Narushima, Mitsunaga ^a   Iida, Takuya ^a   Koshima, Isao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; EARLY DIAGNOSIS; FEMALE; HOSPITALIZATION; HUMAN; LEG; LYMPH VESSEL; LYMPHEDEMA; LYMPHOGRAPHY; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; COHORT STUDIES; COLORING AGENTS; EARLY DIAGNOSIS; FEMALE; HUMANS; INDOCYANINE GREEN; LOWER EXTREMITY; LYMPHATIC VESSELS; LYMPHEDEMA; LYMPHOGRAPHY; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 80053036553     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182268da8     Document Type: Article

References (62)

1. Homans J. The treatment of elephantiasis of the legs: Preliminary report. N Engl J Med. 1936;215:1099-1104.
2. Szuba A, Cooke JP, Yousuf S, Rockson SG. Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med. 2000;109:296-300.
3. Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: A comprehensive review. Ann Plast Surg. 2007;59:464-472. (Pubitemid 47494139)
4. Kerchner K, Fleischer A, Yosipovitch G. Lower extremity lymphedema update: Pathophysiology, diagnosis, and treatment guidelines. J Am Acad Dermatol. 2008;59:324-331.
5. Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer 1998;83(12 Suppl American):2821-2827. (Pubitemid 29024274)
6. Szuba A, Rockson SG. Lymphedema: Classification, diagnosis and therapy. Vasc Med. 1998;3:145-156. (Pubitemid 28481265)
7. Tiwari A, Cheng KS, Button M, Myint F, Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg. 2003;138:152-161. (Pubitemid 36216279)
8. Partsch H, Flour M, Smith PC; International Compression Club. Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scientific evidence: Under the auspices of the IUP. Int Angiol. 2008;27:193-219.
9. Cohen SR, Payne DK, Tunkel RS. Lymphedema: Strategies for management. Cancer 2001;92:980-987.
10. Moseley AL, Carati CJ, Piller NB. A systemic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol. 2007;18:639-646. (Pubitemid 46523265)
11. Szolnoky G, Lakatos B, Keskeny T, et al. Intermittent pneumatic compression acts synergistically with manual lymphatic drainage in complex decongestive physiotherapy for breast cancer treatment-related lymphedema. Lymphology 2009;42: 188-194.
12. Yamada Y. Studies on lymphatico-venous anastomoses in lymphedema. Nagoya J Med. 1969;32:1-21.
13. Koshima I, Inagawa K, Urushibara K, Moriguchi T. Super-microsurgical lymphaticovenular anastomosis for the treatment of lymphedema in the upper extremities. J Reconstr Microsurg. 2000;16:437-442.
14. Koshima I, Nanba Y, Tsutsui T, Takahashi Y, Itoh S. Long-term follow-up after lymphaticovenular anastomosis for lymphedema in the leg. J Reconstr Microsurg. 2003;19:209-215. (Pubitemid 36666310)
15. Koshima I, Nanba Y, Tsutsui T, Takahashi Y, Itoh S, Fujitsu M. Minimal invasive lymphaticovenular anastomosis under local anesthesia for leg lymphedema: Is it effective for stage III and IV? Ann Plast Surg. 2004;53:261-266. (Pubitemid 39278818)
16. Nagase T, Gonda K, Inoue K, et al. Treatment of lymphedema with lymphaticovenular anastomosis. Int J Clin Oncol. 2005;10: 304-310.
17. Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: A prospective study. Plast Reconstr Surg. 2010;126:752-758.
18. Narushima M, Mihara M, Yamamoto Y, Iida T, Koshima I, Mundinger GS. The intravascular stenting method for treat-mentof extremity lymphedema with multiconfiguration lym-phaticovenous anastomoses. Plast Reconstr Surg. 2010;125: 935-943
19. Yamamoto T, Narushima M, Kikuchi K, et al. Lambda-shaped anastomosis with intravascular stenting method for safe and effective lymphaticovenular anastomosis. Plast Reconstr Surg. 2011;127:1987-1992.
20. Ogata F, Azuma R, Kikuchi M, Koshima I, Morimoto Y. Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling. Ann Plast Surg. 2007;58:652-655. (Pubitemid 46816803)
21. Ogata F, Narushima M, Mihara M, Azuma R, Morimoto Y, Koshima I. Intraoperative lymphography using indocyanine green dye for near-infrared fluorescence labeling in lymphedema. Ann Plast Surg. 2007;59:180-184. (Pubitemid 47220423)
22. Unno N, Inuzuka K, Suzuki M, et al. Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. J Vasc Surg. 2007;45:1016-1021. (Pubitemid 46634931)
23. Unno N, Nishiyama M, Suzuki M, et al. Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography. Eur J Vasc Endovasc Surg. 2008;36:230-236. (Pubitemid 351952341)
24. Unno N, Nishiyama M, Suzuki M, et al. A novel method of measuring human lymphatic pumping using indocyanine green fluorescence lymphography. J Vasc Surg. 2010;52:946-952.
25. Yamamoto T, Narushima M, Doi K, et al. Characteristic in-docyanine green lymphography findings in lower extremity lymphedema: The generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Re-constr Surg. 2011;127:1979-1986.
26. Yamamoto T, Matsuda N, Todokoro T, et al. Lower extremity lymphedema index: A simple method for severity evaluation of lower extremity lymphedema. Ann Plast Surg. Epublished ahead of print March 14, 2011.
27. Kwan ML, Darbinian J, Schmitz KH, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: The pathways study. Arch Surg. 2010;145:1055-1063.
28. Todo Y, Yamamoto R, Minobe S, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenec-tomy. Gynecol Oncol. 2010;119:60-64.
29. Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17:2764-2772.
30. Tada H, Teramukai S, Fukushima M, Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer 2009;5:47.
31. Füller J, Guderian D, Köhler C, Schneider A, Wendt TG. Lymph edema of the lower extremities after lymphadenec-tomy and radiotherapy for cervical cancer. Strahlenther Onkol. 2008;184:206-211. (Pubitemid 351508127)
32. Koshima I, Kawada S, Moriguchi T, Kajiwara Y. Ultrastruc-tural observations of lymphatic vessels in lymphedema in human extremities. Plast Reconstr Surg. 1996;97:397-405; discussion 406-407. (Pubitemid 126425841)
33. Sistrunk WE. Modification of the operation for elephantiasis. JAMA 1918;71:800.
34. Thompson N. The surgical treatment of advanced postmas-tectomy lymphoedema of the upper limb: With the late results of treatment by the buried dermis flap operation. Scand J Plast Reconstr Surg. 1969;3:54-60.
35. Kinmonth JB, Hurst PA, Edwards JM, Rutt DL. Relief of lymph obstruction byuse ofa bridgeof mesentery and ileum. Br J Surg. 1978;65:829-833. (Pubitemid 9069738)
36. Dellon AL, Hoopes JE. The Charles procedure for primary lymphedema: Long-term clinical results. Plast Reconstr Surg. 1977;60:589-595. (Pubitemid 8212256)
37. Goldsmith HS, De los Santos R, Beattie EJ Jr. Relief of chronic lymphedema by omental transposition. Ann Surg. 1967;166:573-585.
38. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009;374:477-490.
39. Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet 2010;375:1030-1047.
40. Benson JR, Jotoi I, Keisch M, Esteva FJ, Makris A, Jordan VC. Early breast cancer. Lancet 2009;373:1463-1479.
41. Henze E, Schelbert HR, Collins JD, Najafi A, Barrio JR, Bennett LR. Lymphoscintigraphy with Tc-99m-labeled dex-tran. J Nucl Med. 1982;23:923-929.
42. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43-57. (Pubitemid 36077712)
43. Tomczak H, Nyka W, Lass P. Lymphoedema: Lymphoscin-tigraphy versus other diagnostic techniques-A clinician's point of view. Nucl Med Rev Cent East Eur. 2005;8:37-43. (Pubitemid 40916653)
44. Modi S, Stanton AW, Mortimer PS, Levick JR. Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: A critical review of lympho-scintigraphy. Lymphat Res Biol. 2007;5:183-202. (Pubitemid 350172944)
45. Maegawa J, Mikami T, Yamamoto Y, Satake T, Kobayashi S. Types of lymphoscintigraphy and indications for lymphati-covenous anastomosis. Microsurgery 2010;30:437-442.
46. Pani SP, Vanamail P, Yuvaraj J, et al. Limb circumference measurement for recording edema volume in patients with filarial lymphedema. Lymphology 1995;28:57-63.
47. Stanton AW, Badger C, Sitzia J. Non-invasive assessment of the lymphedematous limb. Lymphology 2000;33:122-135.
48. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper-extremity volume estimates: Comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther. 2003;83:134-145. (Pubitemid 36169384)
49. Deltombe T, Jamart J, Recloux S, et al. Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology 2007;40:26-34. (Pubitemid 46676825)
50. Gjorup C, Zerahn B, Hendel HW. Assessment of volume measurement of breast cancer-related lymphedema by three methods: Circumference measurement, water displacement, and dual energy X-ray absorptiometry. Lymphat Res Biol. 2010; 8:111-119.
51. Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: Derivative lymphatic-venous microsurgery. World J Surg. 2004;28:609-613. (Pubitemid 38802800)
52. Campisi C, Eretta C, Pertile D, et al. Microsurgery for treatment of peripheral lymphedema: Long-term outcome and future perspectives. Microsurgery 2007;27:333-338. (Pubitemid 46897042)
53. Witte CL, Witte MH. Disorders of lymph flow. Acad Radiol. 1995;2:324-334.
54. Dissanayake S, Watawana L, Piessens WF. Lymphatic pathology in Wuchereria bancrofti microfilaraemic infections. Trans R Soc Trop Med Hyg. 1995;89:517-521.
55. Suresh S, Kumaraswami V, Suresh I, et al. Ultrasonographic diagnosis of subclinical filariasis. J Ultrasound Med. 1997;32: 617-621.
56. Cheville AL. Current and future trends in lymphedema management: Implications for women's health. Phys Med Rehabil Clin North Am. 2007;18:539-553. (Pubitemid 47126887)
57. Damstra RJ, van Steensel MA, Boomsma JH, Nelemans P, Veraart JC. Erysipelas as a sign of subclinical primary lym-phoedema: A prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol. 2008;158:1210-1215. (Pubitemid 351692855)
58. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Ger-ber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 2008;112:2809-2819. (Pubitemid 351969228)
59. Lohrmann C, Foeldi E, Langer M. MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema. Micro-vasc Res. 2009;77:335-339.
60. Kinneard G. Diphtheria in the tropics: A subclinical disease in negroes. BMJ. 1935;1:201-202.
61. Cushing GW. Subclinical hypothyroidism: Understanding is the key to decision making. Postgrad Med. 1993;94:95-97, 100-102, 106-107.
62. Ross NS. Epidemiology of Cushing's syndrome and sub-clinical disease. Endocrinol Metab Clin North Am. 1994;23: 539-546. (Pubitemid 24300124)